Connect with us

Health

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities – News-Medical.Net

The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications…

Published

on

Article feature image

The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).
In a review article in Trends in Cancer, the team presented evidence that immunotherapies such as immune checkpoint inhibitors (which enable T cells to attack and kill cancer…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Finerenone reduces risk for new-onset AF in diabetic kidney disease – Healio
Article feature image
Qld based team develop antiviral treatment that could reduce virus by 99.99 per cent – PerthNow